Skip to main content
Back to News
Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st...
Technology
1 min read

Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st...

The AMW Read

The launch of GPT-4 scale models specifically for programmable gene insertion represents a significant advancement in the 'Bio-platform bull' debate, moving vertical AI from simple documentation/ops into high-value predictive engineering.
NoveltySignificance
Healthcare & Bio · Player Map

Basecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a strategic investment from Nvidia NVentures. Developed with Microsoft and Nvidia, these GPT-4 scale models successfully designed active proteins for 100 percent of tested disease target sites. By enabling large-scale DNA insertions beyond the reach of CRISPR, this platform shifts genetic medicine from trial-and-error to predictive, software-driven engineering. 🧬💻

#AI #Biotech #Nvidia #Genomics #Innovation

Read Original

How This Connects

Based on Healthcare & Bio · Player Map

  1. 3d agoInnovaccer acquires CaduceusHealth to expand AI-led revenue cycle managementInnovaccer
  2. 1w agoIsomorphic Labs raises $2.1B led by Thrive Capital in largest AI drug-discovery roundIsomorphic Labs
  3. 3w agoOpenAI model outperforms doctors in ER diagnoses, achieving 67% accuracy vs 55%OpenAI
  4. 1mo agoOpenAI Launches GPT-Rosalind, a Specialized Frontier Model for Life Sciences Research and Drug DiscoveryOpenAI
  5. 4mo agoBasecamp Research has launched the EDEN AI models for programmable gene insertion, supported by a st... · THIS ARTICLE

Related News

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard